FeesSafety
Pluang+

GoldMining releases 2025 Sustainability Report showing zero lost-time incidents and strong environmental performance.

Others
23 Oct 2026
PRNewsWire
View Source
Bullish
GoldMining releases 2025 Sustainability Report showing zero lost-time incidents and strong environmental performance.

GoldMining Inc. published its 2025 Sustainability Report highlighting zero lost-time incidents, no environmental incidents, and 100% drill site reclamation in fiscal 2025. The report emphasizes the company's commitment to safety, environmental stewardship, and local community support, including hiring all staff locally and screening suppliers for human rights risks. The company aligns its sustainability goals with the UN Sustainable Development Goals and plans to continue advancing exploration projects responsibly while minimizing environmental impact. CEO Alastair Still reaffirmed the focus on building a safe and sustainable foundation for future growth.

GoldMining's 2025 Sustainability Report is the subject here, providing context for readers interested in the Basic Materials sector. For readers following Basic Materials stocks on Pluang, 28 out of 83 priced US stocks rose while 51 fell. Notable movers include TECK at USD 60.00 with a 1-day change of +1.87% and 100% sell order activity, CENX at USD 32.15 down 1.53%, and IAUX at USD 1.47 up 1.38%. This data is as of Oct 23, 2026 17:11 WIB.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
16 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App